Abandoning FEV1/FVC <0.70 to Detect Airway Obstruction

Slides:



Advertisements
Similar presentations
Pharmacokinetics of Theophylline in Hepatic Disease
Advertisements

Tell-tale Telangiectasias
Colloquium on Therapy of Right Heart Failure
Environmental Causes of Cancer of the Lung Other Than Tobacco Smoke
When to Be Rash About a Fever and Headache
Right-Sided Chest Pain with Progressive Dyspnea
Volume 102, Issue 3, Pages (September 1992)
Epidemiology and Treatment of Lung Cancer in Seattle
Bovine Tuberculosis Eradication
Robert Pickering, M.D, Fernando J. Martinez, M.D  CHEST 
Hyperbaric Oxygenation in Cardiac and Pulmonary Disease
W.L. Coudon, M.D., J.O. Harris, M.D.  CHEST 
Annals of Emergency Medicine 
Air Pollution and Chest Disease
The Use of Statins and Lung Function in Current and Former Smokers
Volume 105, Issue 5, Pages (May 1994)
Clinical and Personality Profiles and Survival in Patients With COPD
Fever, Skin Eruption, Low Serum Gammaglobulin in a Child with Leukemia
Volume 84, Issue 6, Pages (December 1983)
Bacterial Infection and the Pathogenesis of COPD
Volume 113, Issue 4, Pages (April 1998)
Frank W. Ewald, MD, FCCP, Albert H. Scherff, MD  CHEST 
Chronic Cough Due to Nonasthmatic Eosinophilic Bronchitis
Chronic Cough Due to Nonasthmatic Eosinophilic Bronchitis
The Therapeutic Potential of Hyaluronan in COPD
Volume 153, Issue 4, Pages (April 2018)
Annals of Emergency Medicine 
Zaid J. Yaqoob, MD, Sadeer G. Al-Kindi, MD, Joe G. Zein, MD  CHEST 
Precision Medicine Urgency
Spread the Word About CHEST in 2018
Millennial Health Care
Observers in the Medical Setting
Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation  Nicholas J. Gross, MD,
Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
Details and Difficulties Regarding the New Lung Cancer Staging System
Airway Stenting for Patients With Benign Airway Disease and the Food and Drug Administration Advisory  Lund Mark E. , MD, FCCP, Force Seth , MD, FCCP 
Exercise-Induced Bronchoconstriction in Healthy Athletes-To the Editor
Tako-Tsubo Cardiomyopathy: Response
Point: Should Medicare Allow Respiratory Therapists to Independently Practice and Bill for Educational Activities Related to COPD? Yes  Thomas M. Fuhrman,
Sundeep Salvi, MD, DNB, PhD, FCCP, Peter J. Barnes, DM, FCCP  CHEST 
Volume 84, Issue 6, Pages (December 1983)
Robert M. Hoffman, MD, Ronald A. Stiller, MD, PhD, FCCP  CHEST 
Point: Should We Abandon FEV1/FVC <0
Possible Role of Statins in COPD-Related Pulmonary Hypertension
Volume 97, Issue 1, Pages (January 1990)
Brahms' Lullaby Revisited
Tako-Tsubo Cardiomyopathy: Response
Volume 134, Issue 2, Pages (August 2008)
Evolution in Reimbursement for Sleep Studies and Sleep Centers
Bedside Calibration Of Pulmonary Artery Catheters
Invasive Pulmonary Aspergillosis
Pulmonary Manifestations in a Case of Multiple Myeloma
Do CIs Give You Confidence?
Myocardial Sarcoidosis Unresponsive to Steroids
Nasal Airflow in Sleep-Disordered Breathing
Volume 42, Issue 2, Pages (August 1962)
Calcification of the Coronary Artery
Post-bronchodilator forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC) ratio in subjects aged >50 yrs. Post-bronchodilator forced expiratory.
Volume 72, Issue 5, Pages (November 1977)
Infective Exacerbations of COPD
Myocardial Dysfunction in Sepsis Recent Insights
Controlled Suction during Flexible Fiberoptic Bronchoscopy
Digitalis and Angina Pectoris
Systemic Inflammation, COPD, and Pulmonary Hypertension
Lung Density in Extremely Large Healthy Lungs
Exercise Testing in Variant Angina
New Members of the Editorial Board
John Reid, MD, Donald Cockcroft, MD  CHEST 
National Asthma Education Program
FEV1/FVC ratios for females in the National Health and Nutrition Examination Survey III study are plotted against their age. FEV1/FVC ratios for females.
Presentation transcript:

Abandoning FEV1/FVC <0.70 to Detect Airway Obstruction Bas Robberts, MD, Tjard Schermer, PhD  CHEST  Volume 139, Issue 5, Pages 1253-1254 (May 2011) DOI: 10.1378/chest.10-3099 Copyright © 2011 The American College of Chest Physicians Terms and Conditions

Figure 1 Association between FEV1/FVC and age in male symptomatic current and ex-smokers aged ≥ 50 years referred for spirometric testing by their primary care physician (n = 3,473). The horizontal red line indicates the fixed 0.70 FEV1/FVC cutoff point that is currently recommended by all major clinical COPD guidelines; the black diagonal line indicates the lower limit of normal for healthy nonsmoking men. Black circles = true negatives; green circles = true positives (unique subjects considered to have airflow obstruction according to both definitions); red circles = false positives (subjects in whom discordant conclusions regarding the presence of airflow obstruction are drawn, n = 558, 16% of all subjects). (Adapted with permission from Schermer et al.4) CHEST 2011 139, 1253-1254DOI: (10.1378/chest.10-3099) Copyright © 2011 The American College of Chest Physicians Terms and Conditions